Showing 7821-7830 of 20882 results for "".
- Priming, Shaping, and Polishing: In Search of a HIV Vaccinehttps://reachmd.com/news/priming-shaping-and-polishing-in-search-of-a-hiv-vaccine/2456865/Worldwide, an estimated, 40 million people live with HIV. Two-thirds of this group on the African continent. In 2022, more than 600,000 people died from HIV-related causes and more than 1.3 million were infected. There is no vaccine against the world's second most deadly infection,
- Bladder Tumors Reduced by 90% Using Nanorobotshttps://reachmd.com/news/bladder-tumors-reduced-by-90-using-nanorobots/2456867/The research, leaded by the IBEC with the participation of the UAB, demonstrates on mice how these tiny nanomachines are propelled by urea present in urine and precisely target the tumour, attacking it with a radioisotope carried on their surface.
- U.S. Heart Disease Deaths Linked with Substance Use Rose 4% Per Year Between 1999-2019https://reachmd.com/news/us-heart-disease-deaths-linked-with-substance-use-rose-4-per-year-between-1999-2019/2456862/Research Highlights: Despite drops in overall cardiovascular disease deaths from 1999-2019, cardiovascular disease deaths in which substance use was cited as a contributing factor increased an average of 4% per year, with the death rate accelerating to 6.2%
- Snow Shoveling, Cold Temperatures Combine for Perfect Storm of Heart Health Hazardshttps://reachmd.com/news/snow-shoveling-cold-temperatures-combine-for-perfect-storm-of-heart-health-hazards/2456863/DALLAS, Jan. 11, 2024 — Weather forecasters may call it ‘white fluffy stuff,’ however, snow can be a bigger danger than many people may realize. According to the American Heart Association, celebrating its
- Pazopanib Shows Activity in EWSR1-NFATC2 Bone Sarcomahttps://reachmd.com/news/pazopanib-shows-activity-in-ewsr1-nfatc2-bone-sarcoma/2456858/"Pazopanib is a multi-kinase inhibitor that is currently approved for treatment of advanced renal cell carcinoma and chemotherapy-refractory soft tissue sarcoma."BUFFALO, NY- January 12, 2024 – A new case report was published in
- News Media Trigger Conflict for Romantic Couples with Differing Political Viewshttps://reachmd.com/news/news-media-trigger-conflict-for-romantic-couples-with-differing-political-views/2456860/Couples with differing political views and identities face unique challenges in their consumption of news, which can create significant stress on their relationship, University of Illinois U
- Building Trust and Saving Lives: A Community Approach to Genetic Educationhttps://reachmd.com/news/building-trust-saving-lives-a-community-approach-to-genetic-education/2456856/Changes to DNA, known as mutations, can increase the likelihood of developing cancer. Specifically, people with mutations in their BRCA 1 and 2 genes are substantially more likely to develop hereditary breast and ovarian cancers. But how do people know if they have these mutations? Geneti
- Obesity Linked to Detection of Blood Cancer Precursorhttps://reachmd.com/news/obesity-linked-to-detection-of-blood-cancer-precursor/2456853/Credit: CC0 Public Domain Individuals with obesity are more likely to have monoclonal gammopathy of undetermined significanc
- How Gum Disease Aggravates Chronic Obstructive Pulmonary Diseasehttps://reachmd.com/news/how-gum-disease-aggravates-chronic-obstructive-pulmonary-disease/2456851/Severe gum disease has been linked to the progression of chronic obstructive pulmonary disease, or COPD, but an understanding of how the connection plays out in the immune system remains unclear. This week in mSystems, a
- Upadacitinib in Atopic Dermatitis: New Safety Data Encourages Practitioners and Patientshttps://reachmd.com/news/long-term-safety-of-upadacitinib-in-atopic-dermatitis-5-year-analysis-unveils-encouraging-results/2462210/A recent analysis reveals that upadacitinib, an oral Janus kinase 1 (JAK1) inhibitor, maintains its safety profile over a span of 5 years, aiding individuals